Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Is it cancer? A combination non-invasive approach to determine if indeterminate pulmonary nodules are cancerous
From Dr. Paul Lampe, Translational Research Program and Cancer Epidemiology, Prevention and Control of the Cancer Consortium, and Dr. Paul Kinahan, University of Washington.
Lung cancer expert Dr. McGarry Houghton receives Satya and Rao Remala Family Endowed Chair
New sustained funding will represent Fred Hutch’s first endowed chair for lung cancer
Neutrophils disguise tumors by synthesizing and secreting arginase
From the Houghton lab and collaborating Randolph lab, Clinical Research and Public Health Sciences Divisions
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Out of pocket costs and patient outcomes in EGFR and ALK positive NSCLC
From the Goulart and Ramsey Group
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy
Natural language processing as a research aid
From the Divisions of Clinical Research and Public Health Sciences
Good News at Fred Hutch
<p>Dr. Aude Chapuis named Damon Runyon Clinical Investigator; Dr. Jonathan Bricker receives $3.1M NCI grant to test quit-smoking smartphone app; Dr. Hans-Peter Kiem appointed chair of NIH Recombinant DNA Advisory Committee; Dr. Julie Overbaugh receives award from Association for Women in Science</p>